Dr. Bernadette DunhamSpeaker and Booking Agent Information

These include animals used to produce human meals, as well as pet (or companion) animals and lesser species such as animals other than cattle, swine, chickens, turkeys, horses, dogs, and cats. Dr. Dunham was in charge of ensuring the safety and efficacy of animal medicines and medicated feeds, as well as the safety of food from treated animals. Dr.

Dunham coordinated outreach to educate consumers as well as the regulated industry; the careful evaluation of data on proposed veterinary products before allowing them to be marketed; the discovery of violative marketed products through surveillance programs; the initiation of legal action, if necessary, to bring violators into compliance with the law; and research to support Center responsibilities. Dr.

Dunham was CVM's Deputy Director prior to becoming Director in 2008. From August 2006 until January 2008, Dr. Dunham was also the Director of CVM's Office of Minor Use and Minor Species. She joined CVM as the Deputy Director of the Office of New Animal Drug Evaluation in December 2002. From 1996 until 2012, Dr.

Dunham was an Adjunct Professor in the Department of Biomedical Sciences and Pathobiology at the Virginia-Maryland Regional College of Veterinary Medicine. She spoke on a range of subjects, including new challenges and possibilities in veterinary care and the importance of consensus building in policy formation. Dr.

Dunham formerly worked as the Assistant Director of the American Veterinary Medical Association's Governmental Relations Division in Washington, D.C., from 1995 to 2001. In that capacity, she was involved in the development and implementation of AVMA policies, objectives, and programs, with a focus on Federal legislation and regulatory problems. Dr.

Dunham's job also included identifying Congressional and regulatory concerns that might have an influence on the veterinary medical profession, as well as devising methods to address these difficulties. Dr. Dunham was the Director of Laboratory Animal Medicine and Adjunct Professor of Pharmacology at the State University of New York Health Science Center in Syracuse, New York, from 1989 to 1995.

The molecular control of cardiac gap junction proteins was the focus of Dr. Dunham's study. From 1987 to 1988, she completed a post-doctoral residency program in the Department of Pathology at Cornell University's New York State College of Veterinary Medicine in Ithaca, N.Y. From 1984 to 1987, Dr. Dunham worked as a Research Assistant Professor at Boston University. Dr.

Dunham worked in private clinical practice in Ontario, Canada, from 1975 to 1979 before returning to university to obtain her Ph.D. Dr. Dunham earned her DVM in 1975 from the Ontario Veterinary College at the University of Guelph in Ontario, Canada, and her Ph.D. in cardiovascular physiology in 1984 from Boston University in Boston, Massachusetts. Dr.

Dunham is a member of the American Veterinary Medical Association, the American Academy of Veterinary Pharmacology and Therapeutics, the National Academies of Practice, and the American Veterinary Epidemiology Society, as well as an Honorary Diplomate.

She has served on peer review panels for the National Academies of Science, the American Heart Association's New York State Affiliate, the United States Department of Agriculture's Cooperative State Research, Education, and Extension Service, Competitive Programs, and the National Institutes of Health. Dr. Dunham also chaired the 18th Session of the Codex Alimentarius Committee on Veterinary Drug Residues in Foods.